InnovexLab Women's health panel
Organisms associated with bacterial vaginosis, vulvovaginal candidiasis and other causes of vaginitis, together with protective lactobacilli.
General medical information for education only, not medical advice. Targets as listed on InnovexLab’s requisition forms (general requisition form). Detection of a target does not by itself establish infection or determine treatment; results are interpreted by the ordering clinician with the clinical picture and, where indicated, culture and susceptibility testing.
When to consider testing
Vaginal symptoms with more than one possible cause: abnormal discharge, odor, itching or irritation.
Interpretation
Lactobacilli and several BV-associated organisms are interpreted together as a picture of the vaginal microbiome; some organisms are normal flora.
Targets (20)
Select a target for its clinical summary, symptoms, resistance and treatment considerations.
Bacterial vaginosis-associated bacteria (5)
- Gardnerella vaginalisA Gram-variable coccobacillus that overgrows in bacterial vaginosis when protective lactobacilli decline.
- Atopobium (Fannyhessea) vaginaeAnaerobic bacteria strongly associated with bacterial vaginosis; molecular assays use them, together with Gardnerella and lactobacilli, to characterize the vaginal microbiome.
- BVAB2Anaerobic bacteria strongly associated with bacterial vaginosis; molecular assays use them, together with Gardnerella and lactobacilli, to characterize the vaginal microbiome.
- Megasphaera type 1Anaerobic bacteria strongly associated with bacterial vaginosis; molecular assays use them, together with Gardnerella and lactobacilli, to characterize the vaginal microbiome.
- Megasphaera type 2Anaerobic bacteria strongly associated with bacterial vaginosis; molecular assays use them, together with Gardnerella and lactobacilli, to characterize the vaginal microbiome.
Lactobacilli (3)
- Lactobacillus crispatusProtective Gram-positive rods that dominate a healthy vaginal microbiome by producing lactic acid.
- Lactobacillus inersProtective Gram-positive rods that dominate a healthy vaginal microbiome by producing lactic acid.
- Lactobacillus jenseniiProtective Gram-positive rods that dominate a healthy vaginal microbiome by producing lactic acid.
Other bacteria (8)
- Enterococcus faecalisA Gram-positive coccus in pairs and short chains from the gut; hardy in the healthcare environment.
- Escherichia coliA normal inhabitant of the human gut and the most common cause of urinary tract infection.
- Staphylococcus aureusA Gram-positive coccus in clusters carried on the skin and in the nose of many people, and a major cause of skin, soft-tissue and invasive infection.
- Streptococcus agalactiae (group B)A Gram-positive coccus that colonizes the gut and genital tract.
- Neisseria gonorrhoeaeA Gram-negative diplococcus transmitted sexually and the cause of gonorrhea.
- Mycoplasma hominisA genitourinary bacterium without a cell wall that often colonizes without causing disease.
- Ureaplasma parvumGenitourinary bacteria without a cell wall that commonly colonize the urogenital tract.
- Ureaplasma urealyticumGenitourinary bacteria without a cell wall that commonly colonize the urogenital tract.
Yeasts (4)
- Candida albicansThe most common Candida yeast, part of normal oral, gut and vaginal flora.
- Candida glabrataNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida parapsilosisNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida tropicalisNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
Sources
- CDC. Bacterial vaginosis (STI Treatment Guidelines).
- CDC. Vulvovaginal candidiasis (STI Treatment Guidelines).
- CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.